Concourse Financial Group Securities’s TransCode Therapeutics RNAZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6619 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7227 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7223 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7234 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7232 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7163 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6997 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6833 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6590 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6602 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6428 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6370 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6252 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6203 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6016 |
|